ESG

New research reveals a daily serving of peanut butter can improve muscle power in older adults, offering an affordable way to maintain independence.

A new national program offers free, private mental health support to Canadian women veterans, addressing a silent crisis of trauma and systemic barriers.

The firm's record performance highlights a boom in specialized lending, fueled by green tech demand and the voracious power needs of AI data centers.

Nashville firm M2 Group launches a new design division, hiring Brian Gallagher to merge creative placemaking with its engineering and survey foundation.

SEAM, Inc. appoints a new COO and CMO, signaling a strategic move to scale its social equity certification and meet the growing demand for people-first real estate.

Securus Monitoring touts high-tech supervision tools for modern reentry, but its parent company's controversial history casts a long shadow over its promises.

Once a failing firm, Aurelion Inc. bet its future on tokenized gold. The gamble paid off with a profitable quarter, but regulatory risks loom large.

After a strong Q4, Amprius launches a strategic roadshow to pitch its high-energy silicon anode batteries to investors and key aerospace and defense players.

A new partnership gives thousands of young athletes in Las Vegas free recovery tech while a unique manufacturing model boosts the local economy.

The organic food pioneer gets 37 products certified under a new standard, signaling a major shift toward transparency in the fight against ultra-processed food.

With its pivotal trial fully enrolled, Liberate Medical’s VentFree device aims to shorten ICU stays, reduce complications, and cut healthcare costs.

EFESO Management Consultants targets the booming mining and metals sector, launching a new practice to help firms navigate supply chain shifts and ESG pressures.

A novel sputum test could end the trial-and-error approach for millions with chronic respiratory disease, promising a new era of personalized medicine.

CTL appoints Dan Rodgers, a finance leader from Nike and PwC, to pivot its financial strategy towards aggressive, sustainable growth in the tech lifecycle market.

With a soaring stock and a breakthrough CAR-T therapy, Immix Biopharma is set to capture investor attention. What's behind the hype for its lead drug, NXC-201?

With the appointment of MeMe McNairy-Glenn, Cresset signals a major push to capture the elite wealth market and top advisor talent across the nation.

Recognized by The Hackett Group, Globality's agentic AI is proving its mettle by automating complex procurement and delivering massive savings for giants like BT.

A new partnership leverages advanced AI and metabolomics to find novel drug targets for rare metabolic disorders, offering new hope for millions worldwide.

A new agreement could see South Korea's INNOSPACE launch from Canada, positioning Spaceport Nova Scotia as a key player in the global space race.

An AI firm known for fighting cancer is now partnering with Unilever, signaling a new era of biologically personalized consumer products and new ethical questions.